RSS

antimicrobial resistance (AMR)

Scientists at the University of Glasgow have discovered an important element in understanding bacterial evolution and ultimately antibiotic resistance. Read more

News

Two pharmaceutical companies have collectively received over $10 million to help develop new antibiotics. Read more

News

The National Institute for Health and Care Excellence (NICE) has recommended shorter courses of antibiotics in an effort to cut down on overuse and the risk of antibiotic resistant infections. Read more

News

Pharmaceutical companies will be paid to develop new drugs for resistant infections in a new incentive scheme launched by the NHS. Read more

News

The UK’s chief medical officer, professor Dame Sally Davies has been appointed special envoy on antimicrobial resistance (AMR), public health minister Seema Kennedy has announced. Read more

News

Biotech company Oxford Drug Design has been awarded over £8 million to develop new antibiotics effective against drug-resistant superbugs. Read more

News

A new global tool has been launched to help governments reduce the spread of antimicrobial resistance (AMR). Read more

News

Researchers may have found new ways to kill antibiotic resistant superbugs - by using drugs designed with the help of advanced computer simulations. Read more

News

EPM editor Reece Armstrong writes why international efforts are essential for global health concerns like AMR and vaccination. Read more

Opinion

A new global group has been formed by a range of life science organisations to help combat the threat of antimicrobial resistance (AMR). Read more

News

A new genetic test has been developed to help determine whether people carry bacteria that can cause resistance to two common antibiotics. Read more

News

A European-wide project has been launched to combat antimicrobial resistance (AMR) in community care settings. Read more

News

One of the UK’s leading bodies for helping fight antimicrobial resistance has received a significant funding boost. Read more

News

UK-based biotech company Procarta Biosystems has received €1.5 million funding to help it develop novel therapies to combat antimicrobial resistance (AMR). Read more

News

Darius Hughes, head of vaccines at Pfizer UK, writes about the UK government’s new plan on controlling antimicrobial resistance (AMR). Read more

Opinion

Medical device organisation MediSieve is receiving two grants from Innovate UK for two-year projects beginning this year, totalling £1.56 million. Read more

News

Antimicrobial resistance (AMR) is one of the biggest threats facing the world but arguably not enough is being done by both pharma companies and governments around the world. Read more

Opinion

A new reimbursement model for antibiotics by the NHS and NICE is being labelled as a ‘great breakthrough’. Read more

News

With the potential of antimicrobial resistance (AMR) taking our modern medicine practices back to the stone age, governments around the world need to face the threat head on. Read more

Opinion

A new collaboration between the University of California, Los Angeles and biopharmaceutical company Helperby is looking to develop the next generation of combination antibiotics. Read more

News